Rufinamide

Population Pharmacokinetics of Antiepileptic in Pediatrics

An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303

Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects

Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome

Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects